Ocular Implant Market Report (2022 to 2030) - Johnson and Johnson Services Inc., Carl Zeiss AG, Glaukos Corporation, Morcher GmbH, Allergan Inc. and Hoya Corporation


Pune, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Ocular Implant Market is expected to clock US$ 10.3 billion by 2030 and to grow at a CAGR of 5.2% during the forecast period. This exclusive information is published by Growth Plus Reports in its report titled “Ocular Implant Market – Global Outlook & Forecast 2022-2030

Ocular implants replace part of the diseased eye. After a surgical procedure, they may also deliver the drugs at regular intervals for treatment on the anterior and posterior parts of the eye. The rapidly rising prevalence of ocular disorders caused by various factors such as aging, diabetes, cancer, etc., proportionately boosts the ocular implant market globally.

Get a Sample Copy of the Research Report: http://growthplusreports.com/inquiry/request-sample/ocular-implant-market/7864

Excerpts from ‘Competitive Landscape’

Some prominent players operating in the global ocular implant market are

  • Alcon Inc. (Novartis AG)
  • Johnson and Johnson Services Inc
  • Bausch & Lomb Incorporated
  • Carl Zeiss AG
  • STAAR Surgical Company
  • Glaukos Corporation
  • Morcher GmbH
  • Hoya Corporation
  • Second Sight Medical Products Inc
  • Allergan Inc

Market Drivers

The global ocular implant market is developing at a steady growth rate. The market growth is due to increasing incidences of eye illnesses and the growing geriatric population. Also, heightened technological advancement and growing awareness about such ophthalmic conditions and available treatments positively influence market growth. Rising disposable incomes and an improved healthcare system also support the market growth.

 The global ocular implant market has been analyzed from different perspectives – by product, application, end-users, and region.

Excerpts from ‘By Product Segmentation’

Products have segmented the global ocular implant market into:

  • Intra-Ocular Lens
  • Glaucoma Implants
  • Corneal Implants

Glaucoma implants currently dominate the global ocular implants market, owing to the phenomenal growth in glaucoma prevalence. Furthermore, the rising awareness among the population led by government and private organizations fuels the development of the glaucoma implant segment. In addition, the intra-ocular lens segment also holds a prominent market position due to its broad application base.

Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: http://growthplusreports.com/inquiry/speak-analyst/ocular-implant-market/7864

Excerpts from ‘By Region Segmentation’

Based on regional distribution, the global ocular implant market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

With the highest revenue share, North America leads the global market. The high prevalence of eye disorders and better diagnosis and treatment rates create a strong demand for ocular implants in North America. Furthermore, a robust pipeline with continuous product releases foresees market expansion. The presence of several key market players and favorable reimbursement policies also assist in this region's market growth. Additionally, the market in North America is supported by the quick uptake of novel technologies, a well-established healthcare infrastructure, and a significant healthcare expenditure.

Europe holds the second largest share in this market owing to the rapid adoption of new treatments, fertile healthcare infrastructure, and consistent growth in the geriatric population. In addition, the demand for ocular implants is still developing in the Asia Pacific. The growth in the Asia Pacific market can be attributed to various factors such as improving medical tourism and developing healthcare infrastructure. Furthermore, the rising aged population, increasing prevalence of hypertension and diabetes, and growing awareness about ocular disorders and treatment methods/techniques further fuels the growth of the Asia Pacific ocular implant market.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
  5. GLOBAL OCULAR IMPLANT MARKET- ANALYSIS & FORECAST, BY PRODUCT
    1. Intra-Ocular Lens
    2. Glaucoma Implants
    3. Corneal Implants

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Directly Purchase Premium Copy of Ocular Implant Market Growth Report (2022-2030) at: http://growthplusreports.com/checkout?_token=PgYYOC3MNLTmUtG3PcnPkhwe6YBZPzv1Lm2UfWmv&report_id=7864&license=Single

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

 

Contact Data